Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30)
The summary for the Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30) grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30): Purpose. This Funding Opportunity Announcement (FOA), issued by the National Cancer Institute (NCI), National Institutes of Health (NIH), invites new or renewal (competing) applications for P30 Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers. CCSGs support two types of cancer centers: 1) Comprehensive Cancer Centers, which demonstrate reasonable depth and breadth of research activities in each of three major areas -- laboratory, clinical, and population-based research -- and which have substantial transdisciplinary research that bridges these scientific areas; and 2) Cancer Centers, which are primarily focused on laboratory research, clinical research, population science research, or some combination of these components. The purpose of both types of NCI-designated Cancer Centers is to capitalize on all institutional cancer research capabilities, integrating meritorious programs in laboratory, clinical, and population research into a single transdisciplinary research enterprise across all institutional boundaries. Cancer Centers supported through the P30 grant mechanism are expected: to serve as major sources of discovery of the nature of cancer and of development of more effective approaches to prevention, diagnosis, and therapy; to contribute significantly to the development of shared resources that support research; to collaborate and coordinate their research efforts with other NCI-funded programs and investigators; and to disseminate research findings for the benefit of the community. Mechanism of Support. This Funding Opportunity Announcement (FOA) will utilize the NIH center grant (P30) mechanism. Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications.
Federal Grant Title: | Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30) |
Federal Agency Name: | National Institutes of Health |
Grant Categories: | Education Health |
Type of Opportunity: | Discretionary |
Funding Opportunity Number: | PAR-11-005 |
Type of Funding: | Grant |
CFDA Numbers: | 93.397 |
CFDA Descriptions: | Cancer Centers Support Grants |
Current Application Deadline: | Sep 07, 2013 |
Original Application Deadline: | Sep 25, 2014 |
Posted Date: | Oct 12, 2010 |
Creation Date: | Oct 12, 2010 |
Archive Date: | Oct 08, 2013 |
Total Program Funding: | |
Maximum Federal Grant Award: | |
Minimum Federal Grant Award: | |
Expected Number of Awards: | |
Cost Sharing or Matching: | No |
- Applicants Eligible for this Grant
- Public and State controlled institutions of higher education - Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education - Private institutions of higher education
- Link to Full Grant Announcement
- Information not provided
- Grant Announcement Contact
- NIH OER Webmaster [email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [[email protected]] - Similar Government Grants
- • Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30 Clinical Trial...
- • Administrative Supplements to Cancer Center Support Grants to Strengthen NCI-Supported Com...
- • Administrative Supplements to Cancer Center Support Grants to Strengthen the Research, Tra...
- • Administrative Supplements to Cancer Center Support Grants to Strengthen NCI-Supported Com...
- • Fostering Research Training and Education Programs for Native American Students at NCI-des...
- More Grants from the National Institutes of Health
- • SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Relevant Technologies...
- • Small Business Transition Grant For Early Career Scientists (R41/R42 Clinical Trial Not Al...
- • Cystic Fibrosis Research and Translation Centers (P30 Clinical Trial Optional)
- • Mentored Quantitative Research Development Award (Parent K25 Independent Clinical Trial No...
- • Mentored Quantitative Research Development Award (Parent K25 Independent Basic Experimenta...